Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded potential discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying causes of MSA. One avenue under investigation involves drug-based interventions to influence the activity of specific brain